Summary
The aim of this work is to evaluate the concentration of serum bile acids (SBA) as an index of impaired liver function in systemic lupus erythematosus (SLE) patients versus usual laboratory tests of hepato-biliary system diseases. In patients with SLE the mean fasting SBA concentration was 9.6±1.4μmol/L; in normal subjects the concentration was 2.9±0.6μmol/L (P<0.01). In patients with SLE, mean gamma-glutamyl transpeptidase (GGTP) concentration was 31.5 ±5.9 mU/ml versus 10.05±1.1 mU/ml in controls (P<0.01).The bromsulphalein (BSP) excretion test, 45 minutes after injection, was 6.8±1% in SLE patients versus 2.8±0.4% in controls (P<0.02). No significant difference was found between these two groups of subjects with respect to leucine aminopeptidase (LAP), alkaline phosphatase (AlPh), glutamic-oxalacetic transaminase (SGOT), glutamicpyruvic transaminase (SGPT), bilirubin serum rates. SBA rate was abnormal in 50% of the SLE patients; GGTP rate and the BSP excretion test were abnormal in 38% and 27% respectively. Our findings show the presence of an actual liver impairment in SLE patients, significantly demonstrated by fasting SBA concentration, GGTP rate and BSP excretion test. Other liver function tests are less useful in evaluating hepatic damage in SLE.
Similar content being viewed by others
References
Altomonte, L., et al. Gli acidi biliari sierici nella cirrosi epatica. Min Med 1980, 71, 2483.
Altomonte, L. et al. Le concentrazioni degli acidi biliari sierici come indice di danno epatico nella artrite reumatoide. Min Med 1982, 73, 1695.
Appelbaum, J.J., Job, N., Kern, F. Hepatitis associated with disseminated lupus erythematosus Gastroenterology 1961, 40, 766.
Aronson, A.R., Montgomery, M.M. Chronic liver disease with a “lupus erythematosus-like syndrome”. Arch Intern Med 1959, 104, 544.
Bouchier, I.A.D., Pennington, C.R. Serum bile acids in hepatobiliary disease Gut, 1978, 19, 492.
Cohen, A.S., Canoso, J.J. Criteria for the classification of systemic lupus erythematosus status. Arthritis Rheum 1972, 15, 540.
Dubois, E.I., Tuffonelli, D.L. Clinical manifestations of systemic lupus erythematosus. JAMA, 1964, 190, 112.
Fausa, O., Gjone, E. Serum bile acids concentration in patients with liver disease. Scand J Gastroenterol 1976, 11, 229.
Fraisse, M. et al. The liver in the course of lupus erythematosus disseminatus. J Med Lyon, 1970, 51, 1067.
Froelich, A.L., Van De Putte, I. Chronic hepatitis in lupus erythematosus disseminatus. Acta Gastroenterol Belg, 1966, 29, 683.
Hannes, G.A., Stellaard, F., Paumgartner, G. Increased serum bile acids in cirrhosis with normal transaminases. Digestion, 1982, 25, 217.
Harvey, A.M., et al. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine (Baltimore), 1954, 33, 291.
Hughes, G.R.V. Systemic lupus erythematosus In: Clinical Rhematology, Editors: Mason M. and Currey N.L.F., Philadelphia, J.B. Lippincott Co., 1970, 140.
Kofman, S., Johnson, G.L., Zimmerman, H.J. Apparent hepatic disfunction in lupus erythematosus. Arch Intern Med, 1955, 95, 669.
Makino, I., Nakagawa, S., Mashimo, K. Conjugated and unconjugated serum bile acids levels in patients with hepatobiliary diseases. Gastroenterology, 1969, 56, 1033.
Rothfield, M.F. Systemic lupus erythematosus. In: Rheumatic diseases: diagnosis and management. Editor: Katz W., Philadelphia, J.B. Lippincott CO, 1977, 765.
Runyon, B.A; LaBreque, D.R., Anuras, S. The spectrum of liver disease in systemic lupus erythematosus. Am J Med, 1980, 69, 187.
Tamai, Y.S., Ito, K., Fukosi, M. Application of the preliminary SLE criteria by the ARA to immune hepatitis. Ryumachi, 1974, 14, 88.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Altomonte, L., Zoli, A., Sommella, L. et al. Concentration of serum bile acids as an index of hepatic damage in systemic lupus erythematosus. Clin Rheumatol 3, 209–212 (1984). https://doi.org/10.1007/BF02030756
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02030756